<DOC>
	<DOCNO>NCT01840072</DOCNO>
	<brief_summary>This randomized trial test effect early blood pressure reduction major disability death among patient acute ischemic stroke china .</brief_summary>
	<brief_title>China Antihypertensive Trial Acute Ischemic Stroke</brief_title>
	<detailed_description>We design randomize controlled clinical trial test : - The effectiveness blood pressure reduction among patient acute ischemic stroke ( within 48 hour onset ) primary outcome , combination death within 14 day randomization dependency ( modified Rankin scale ≥3 ) 14 day time discharge , occur 14 day . - The effectiveness blood pressure reduction among patient acute ischemic stroke ( within 48-hours onset ) secondary outcome : - Combination all-cause mortality dependency 3 , 12 , 24 month follow-up - Combined vascular disease event 3 , 12 , 24 month follow-up ( vascular death , non-fatal stroke , non-fatal myocardial infarction , coronary revascularization , hospitalize treated angina , hospitalize treat congestive heart failure , hospitalize treated peripheral arterial disease ) - Recurrent fatal non-fatal stroke 3 , 12 , 24 month follow-up - Neurological functional status measure NIH Stroke Score modify Rankin scale 14 day discharge randomization , 3 , 12 , 24 month follow-up - All-cause mortality 3 , 12 , 24 month follow-up - Duration initial hospitalization - Changes systolic diastolic blood pressure within 24 hour 7 day , 14 day</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Age ≥22 year Ischemic stroke onset within 48 hour confirm image ( CT scan MRI ) study Systolic BP≥140 &lt; 220 mm Hg diastolic BP≥80 mm Hg No contraindication antihypertensive treatment Able willing sign inform consent patient direct family member Individuals hemorrhagic stroke Individuals severe heart failure ( NY Heart Association class III IV ) , myocardial infarction , unstable angina , aortic dissection cerebrovascular stenosis Individuals deep coma Individuals resistant hypertension [ systolic BP ≥170 mm Hg despite use 4 antihypertensive medication half year longer ] Intravenous thrombolytic therapy ( intravenous rtPA ) Individuals unable participate followup examination Current pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Ischemic stroke</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Antihypertensive Agents</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>